NEUROONE MEDICAL TECHNOLOGIES Corp SEC filings NMTC

NEUROONE MEDICAL TECHNOLOGIES Corp has 653 filings in SEC EDGAR's recent list, going back to Oct 4, 2010. Its latest annual report, Form ARS, was filed on Mar 9, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 5, 2026 (results of operations, other events). The company's fiscal year ends on September 30.

NEUROONE MEDICAL TECHNOLOGIES Corp SEC filings
Form Description Filed Period
8-K Current report
Results of operations, Other events
Oct 5, 2026 Oct 5, 2026
4 Insider transaction Sep 8, 2026 Aug 27, 2026
4 Insider transaction Aug 28, 2026 Aug 28, 2026
4 Insider transaction Aug 28, 2026 Aug 28, 2026
4 Insider transaction Aug 28, 2026 Aug 28, 2026
4 Insider transaction Aug 28, 2026 Aug 28, 2026
4 Insider transaction Aug 28, 2026 Aug 28, 2026
8-K Current report
Other events
Aug 27, 2026 Aug 27, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 14, 2026 —
3 Initial insider ownership Jul 14, 2026 Jul 10, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
144 Notice of proposed sale Jun 30, 2026 —
424B5 Prospectus supplement Jun 12, 2026 —
8-K Current report
Other events
Jun 12, 2026 Jun 12, 2026
10-Q/A Amended quarterly report Jun 12, 2026 Mar 31, 2026
SD Specialized disclosure (conflict minerals) May 29, 2026 —
SD Specialized disclosure (conflict minerals) May 29, 2026 —
8-K Current report
Restatement, Regulation FD disclosure
May 22, 2026 May 21, 2026
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 12, 2026 May 12, 2026
8-K Current report
Other events
May 4, 2026 Apr 30, 2026
8-K Current report
Officer or director change
Apr 30, 2026 Apr 24, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 21, 2026 —
8-K Current report
Bylaw or fiscal year change
Apr 14, 2026 Apr 14, 2026
4 Insider transaction Apr 7, 2026 Apr 3, 2026
4 Insider transaction Apr 7, 2026 Apr 3, 2026
4 Insider transaction Apr 7, 2026 Apr 3, 2026
4 Insider transaction Apr 7, 2026 Apr 3, 2026
8-K Current report
Officer or director change, Shareholder vote results
Apr 3, 2026 Apr 3, 2026
4 Insider transaction Apr 1, 2026 Mar 30, 2026
4 Insider transaction Apr 1, 2026 Mar 31, 2026
4 Insider transaction Apr 1, 2026 Mar 31, 2026
4 Insider transaction Mar 16, 2026 Mar 12, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
144 Notice of proposed sale Mar 9, 2026 —
ARS Annual report to shareholders Mar 9, 2026 Sep 30, 2025
DEF 14A Proxy statement Mar 9, 2026 Apr 3, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
3 Initial insider ownership Mar 3, 2026 Mar 1, 2026
PRE 14A Preliminary proxy statement Feb 27, 2026 Apr 3, 2026
8-K Current report
Other events
Feb 25, 2026 Feb 25, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
8-K Current report
Results of operations
Feb 17, 2026 Feb 17, 2026
10-Q Quarterly report Feb 17, 2026 Dec 31, 2025
10-K/A Amended annual report Jan 23, 2026 Sep 30, 2025
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 2, 2026 Dec 18, 2025
3 Initial insider ownership Jan 2, 2026 Dec 18, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 22, 2025 Dec 18, 2025
S-8 Employee stock plan registration Dec 19, 2025 —
8-K Current report
Results of operations
Dec 17, 2025 Dec 17, 2025
10-K Annual report Dec 17, 2025 Sep 30, 2025
SD Specialized disclosure (conflict minerals) Dec 16, 2025 —
SD Specialized disclosure (conflict minerals) Dec 16, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 12, 2025 —
8-K Current report
Listing notice
Nov 5, 2025 Nov 4, 2025
8-K Current report
Results of operations, Other events
Oct 6, 2025 Oct 6, 2025
4 Insider transaction Oct 1, 2025 Sep 30, 2025
4 Insider transaction Oct 1, 2025 Sep 30, 2025
4 Insider transaction Oct 1, 2025 Sep 30, 2025
4 Insider transaction Sep 9, 2025 Sep 5, 2025
144 Notice of proposed sale Aug 20, 2025 —
8-K Current report
Other events
Aug 18, 2025 Aug 18, 2025
8-K Current report
Other events
Aug 15, 2025 Aug 15, 2025
424B5 Prospectus supplement Aug 15, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2025 —
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 13, 2025 —
4 Insider transaction Jul 2, 2025 Jun 30, 2025
4 Insider transaction Jul 2, 2025 Jun 30, 2025
4 Insider transaction Jul 2, 2025 Jun 30, 2025
4 Insider transaction Jun 25, 2025 Jun 23, 2025
4 Insider transaction Jun 25, 2025 Jun 23, 2025
4 Insider transaction Jun 25, 2025 Jun 23, 2025
4 Insider transaction Jun 5, 2025 Jun 4, 2025
4 Insider transaction Jun 3, 2025 Jun 1, 2025
3 Initial insider ownership Jun 3, 2025 Jun 1, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 21, 2025 May 19, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure
May 13, 2025 May 13, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Listing notice
May 9, 2025 May 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 9, 2025 —
4 Insider transaction Apr 21, 2025 Apr 17, 2025
4 Insider transaction Apr 21, 2025 Apr 17, 2025
4 Insider transaction Apr 21, 2025 Apr 17, 2025
4 Insider transaction Apr 21, 2025 Apr 17, 2025
4 Insider transaction Apr 21, 2025 Apr 17, 2025
4 Insider transaction Apr 7, 2025 Apr 4, 2025
4 Insider transaction Apr 7, 2025 Apr 4, 2025
8-K Current report
Material agreement
Apr 7, 2025 Apr 4, 2025
424B5 Prospectus supplement Apr 4, 2025 —
424B5 Prospectus supplement Apr 3, 2025 —
424B5 Prospectus supplement Apr 3, 2025 —
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
144 Notice of proposed sale Mar 14, 2025 —
S-8 Employee stock plan registration Feb 21, 2025 —
4 Insider transaction Feb 20, 2025 Feb 18, 2025
8-K/A Amended current report
Officer or director change, Shareholder vote results
Feb 20, 2025 Feb 14, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 19, 2025 Feb 14, 2025
4 Insider transaction Feb 19, 2025 Feb 14, 2025
4 Insider transaction Feb 19, 2025 Feb 14, 2025
8-K Current report
Shareholder vote results
Feb 14, 2025 Feb 14, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
10-Q Quarterly report Feb 12, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 12, 2025 Feb 12, 2025
DEFA14A Additional proxy material Feb 7, 2025 —
DEFA14A Additional proxy material Feb 5, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 4, 2025 —
8-K Current report
Other events
Feb 4, 2025 Feb 3, 2025
4 Insider transaction Feb 4, 2025 Jan 31, 2025
4 Insider transaction Feb 4, 2025 Jan 31, 2025
4 Insider transaction Feb 4, 2025 Jan 31, 2025
ARS Annual report to shareholders Jan 21, 2025 Sep 30, 2024
DEF 14A Proxy statement Jan 21, 2025 Feb 14, 2025
8-K Current report
Regulation FD disclosure
Jan 14, 2025 Jan 14, 2025
PRER14A Revised preliminary proxy statement Jan 13, 2025 —
8-K Current report
Listing notice
Jan 10, 2025 Jan 8, 2025
PRE 14A Preliminary proxy statement Jan 10, 2025 Jan 10, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Jan 10, 2025 Jan 10, 2025
4 Insider transaction Jan 3, 2025 Dec 31, 2024
4 Insider transaction Jan 3, 2025 Dec 31, 2024
4 Insider transaction Jan 3, 2025 Dec 31, 2024
8-K Current report
Results of operations, Other events
Dec 17, 2024 Dec 17, 2024
10-K Annual report Dec 17, 2024 Sep 30, 2024
4 Insider transaction Dec 3, 2024 Nov 30, 2024
4 Insider transaction Dec 3, 2024 Nov 30, 2024
4 Insider transaction Dec 3, 2024 Nov 30, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 25, 2024 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
8-K Current report
Agreement ended
Nov 8, 2024 Nov 7, 2024
4 Insider transaction Nov 1, 2024 Oct 31, 2024
4 Insider transaction Nov 1, 2024 Oct 31, 2024
4 Insider transaction Nov 1, 2024 Oct 31, 2024
8-K Current report
Material agreement, Other events
Oct 31, 2024 Oct 25, 2024
4 Insider transaction Oct 2, 2024 Sep 30, 2024
4 Insider transaction Oct 2, 2024 Sep 30, 2024
4 Insider transaction Oct 2, 2024 Sep 30, 2024
EFFECT Filing Sep 13, 2024 —
8-K Current report
Officer or director change
Sep 13, 2024 Sep 9, 2024
CORRESP Letter to the SEC Sep 12, 2024 —
S-3/A Amendment no. 1 to form s-3 Sep 12, 2024 —
UPLOAD Letter from the SEC Sep 5, 2024 —
4 Insider transaction Sep 4, 2024 Aug 31, 2024
4 Insider transaction Sep 4, 2024 Aug 31, 2024
4 Insider transaction Sep 4, 2024 Aug 31, 2024
S-3 Shelf registration Aug 30, 2024 —
EFFECT Filing Aug 16, 2024 —
424B5 Prospectus supplement Aug 16, 2024 —
D Filing Aug 16, 2024 —
CORRESP Letter to the SEC Aug 15, 2024 —
S-3/A Amendment no. 1 to form s-3 Aug 14, 2024 —
8-K Current report
Results of operations
Aug 14, 2024 Aug 14, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Material agreement, New debt, Unregistered share sale
Aug 7, 2024 Aug 1, 2024
4 Insider transaction Aug 5, 2024 Aug 1, 2024
4 Insider transaction Aug 2, 2024 Jul 31, 2024
4 Insider transaction Aug 2, 2024 Jul 31, 2024
4 Insider transaction Aug 2, 2024 Jul 31, 2024
8-K Current report
Listing notice
Jul 12, 2024 Jul 11, 2024
4 Insider transaction Jul 2, 2024 Jun 30, 2024
4 Insider transaction Jul 2, 2024 Jun 30, 2024
4 Insider transaction Jul 2, 2024 Jun 30, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jun 21, 2024 Jun 20, 2024
4 Insider transaction Jun 11, 2024 Jun 6, 2024
UPLOAD Letter from the SEC Jun 7, 2024 —
4 Insider transaction Jun 7, 2024 Jun 5, 2024
4 Insider transaction Jun 4, 2024 May 31, 2024
4 Insider transaction Jun 4, 2024 May 31, 2024
4 Insider transaction Jun 4, 2024 May 31, 2024
S-3 Shelf registration May 31, 2024 —
144 Notice of proposed sale May 24, 2024 —
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
4 Insider transaction May 2, 2024 Apr 30, 2024
4 Insider transaction May 2, 2024 Apr 30, 2024
4 Insider transaction May 2, 2024 Apr 30, 2024
4 Insider transaction Apr 23, 2024 Apr 21, 2024
4 Insider transaction Apr 23, 2024 Apr 21, 2024
4 Insider transaction Apr 23, 2024 Apr 21, 2024
4 Insider transaction Apr 2, 2024 Mar 31, 2024
4 Insider transaction Apr 2, 2024 Mar 31, 2024
4 Insider transaction Apr 2, 2024 Mar 31, 2024
8-K Current report
Other events
Mar 26, 2024 Mar 26, 2024
8-K Current report
Shareholder vote results, Regulation FD disclosure
Mar 15, 2024 Mar 14, 2024
4 Insider transaction Mar 4, 2024 Feb 29, 2024
4 Insider transaction Mar 4, 2024 Feb 29, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
NMTC (Nasdaq)
Fiscal year ends
September 30
Incorporated in
DE
Headquarters
Eden Prairie, MN
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1500198
Former names
Original Source Entertainment, Inc. (until May 22, 2017)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.